• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过确定最佳风险临界值来提高分层筛查策略的诊断准确性。

Improving the diagnostic accuracy of a stratified screening strategy by identifying the optimal risk cutoff.

机构信息

Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA.

Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.

出版信息

Cancer Causes Control. 2019 Oct;30(10):1145-1155. doi: 10.1007/s10552-019-01208-9. Epub 2019 Aug 3.

DOI:10.1007/s10552-019-01208-9
PMID:31377875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6736710/
Abstract

BACKGROUND

The American Cancer Society (ACS) suggests using a stratified strategy for breast cancer screening. The strategy includes assessing risk of breast cancer, screening women at high risk with both MRI and mammography, and screening women at low risk with mammography alone. The ACS chose their cutoff for high risk using expert consensus.

METHODS

We propose instead an analytic approach that maximizes the diagnostic accuracy (AUC/ROC) of a risk-based stratified screening strategy in a population. The inputs are the joint distribution of screening test scores, and the odds of disease, for the given risk score. Using the approach for breast cancer screening, we estimated the optimal risk cutoff for two different risk models: the Breast Cancer Screening Consortium (BCSC) model and a hypothetical model with much better discriminatory accuracy. Data on mammography and MRI test score distributions were drawn from the Magnetic Resonance Imaging Screening Study Group.

RESULTS

A risk model with an excellent discriminatory accuracy (c-statistic [Formula: see text]) yielded a reasonable cutoff where only about 20% of women had dual screening. However, the BCSC risk model (c-statistic [Formula: see text]) lacked the discriminatory accuracy to differentiate between women who needed dual screening, and women who needed only mammography.

CONCLUSION

Our research provides a general approach to optimize the diagnostic accuracy of a stratified screening strategy in a population, and to assess whether risk models are sufficiently accurate to guide stratified screening. For breast cancer, most risk models lack enough discriminatory accuracy to make stratified screening a reasonable recommendation.

摘要

背景

美国癌症协会(ACS)建议采用分层策略进行乳腺癌筛查。该策略包括评估乳腺癌风险,对高风险女性同时进行 MRI 和乳房 X 光检查筛查,对低风险女性仅进行乳房 X 光检查筛查。ACS 选择使用专家共识来确定高风险的截止值。

方法

我们提出了一种分析方法,该方法可最大限度地提高基于风险的分层筛查策略在人群中的诊断准确性(AUC/ROC)。输入是给定风险评分的筛查测试分数和疾病几率的联合分布。我们使用乳腺癌筛查的方法,估计了两种不同风险模型的最佳风险截止值:乳腺癌筛查联盟(BCSC)模型和具有更好区分准确性的假设模型。关于乳房 X 光和 MRI 测试分数分布的数据来自磁共振成像筛查研究小组。

结果

具有出色区分准确性(c 统计量 [公式:见文本])的风险模型产生了一个合理的截止值,只有约 20%的女性需要双重筛查。然而,BCSC 风险模型(c 统计量 [公式:见文本])缺乏足够的区分准确性,无法区分需要双重筛查的女性和仅需要乳房 X 光检查的女性。

结论

我们的研究提供了一种优化人群中分层筛查策略的诊断准确性的一般方法,并评估了风险模型是否足够准确以指导分层筛查。对于乳腺癌,大多数风险模型缺乏足够的区分准确性,无法使分层筛查成为合理的建议。

相似文献

1
Improving the diagnostic accuracy of a stratified screening strategy by identifying the optimal risk cutoff.通过确定最佳风险临界值来提高分层筛查策略的诊断准确性。
Cancer Causes Control. 2019 Oct;30(10):1145-1155. doi: 10.1007/s10552-019-01208-9. Epub 2019 Aug 3.
2
3
MRI breast screening in high-risk women: cancer detection and survival analysis.高危女性的乳腺MRI筛查:癌症检测与生存分析
Breast Cancer Res Treat. 2014 Jun;145(3):663-72. doi: 10.1007/s10549-014-2931-9. Epub 2014 Apr 1.
4
Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women.中国女性乳腺癌风险预测模型与筛查策略的比较
J Womens Health (Larchmt). 2017 Mar;26(3):294-302. doi: 10.1089/jwh.2015.5692. Epub 2017 Mar 6.
5
Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.乳腺癌筛查中有无乳腺癌个人史女性的乳腺活检强度和结果。
JAMA Intern Med. 2018 Apr 1;178(4):458-468. doi: 10.1001/jamainternmed.2017.8549.
6
Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.与数字乳腺断层合成术相比,数字乳腺钼靶筛查与间隔期浸润性和高级别乳腺癌风险的关联。
JAMA. 2022 Jun 14;327(22):2220-2230. doi: 10.1001/jama.2022.7672.
7
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.乳腺癌筛查的危害:系统评价更新 2009 年美国预防服务工作组建议。
Ann Intern Med. 2016 Feb 16;164(4):256-67. doi: 10.7326/M15-0970. Epub 2016 Jan 12.
8
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.家族性乳腺癌风险女性的磁共振成像筛查的成本效益。
J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12.
9
Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.针对乳腺癌平均风险女性进行数字化乳腺钼靶筛查,针对高风险女性进行磁共振成像(MRI)筛查:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(3):1-55. Epub 2010 Mar 1.
10
Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.磁共振成像加乳腺 X 线摄影在高风险安大略省乳腺癌筛查计划中的表现指标。
J Natl Cancer Inst. 2020 Feb 1;112(2):136-144. doi: 10.1093/jnci/djz079.

引用本文的文献

1
The Prognostic Quality of Risk Prediction Models to Assess the Individual Breast Cancer Risk in Women: An Overview of Reviews.评估女性个体乳腺癌风险的风险预测模型的预后质量:综述概述
Breast J. 2024 Mar 21;2024:1711696. doi: 10.1155/2024/1711696. eCollection 2024.
2
Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations.基于机器学习的终生乳腺癌风险重新分类与 BOADICEA 模型比较:对筛查建议的影响。
Br J Cancer. 2020 Sep;123(5):860-867. doi: 10.1038/s41416-020-0937-0. Epub 2020 Jun 22.
3
Letter to the editor: Response to Giardiello D, Antoniou AC, Mariani L, Easton DF, Steyerberg EW.致编辑的信:对贾迪埃洛D、安东尼奥AC、马里亚尼L、伊斯顿DF、斯泰尔伯格EW的回应
Breast Cancer Res. 2020 Apr 10;22(1):35. doi: 10.1186/s13058-020-01274-x.

本文引用的文献

1
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.欧洲乳腺影像学会(EUSOBI)以及来自奥地利、比利时、波斯尼亚和黑塞哥维那、保加利亚、克罗地亚、捷克共和国、丹麦、爱沙尼亚、芬兰、法国、德国、希腊、匈牙利、冰岛、爱尔兰、意大利、以色列、立陶宛、摩尔多瓦、荷兰、挪威、波兰、葡萄牙、罗马尼亚、塞尔维亚、斯洛伐克、西班牙、瑞典、瑞士和土耳其的30个国家乳腺放射学机构关于乳腺癌筛查的立场文件
Eur Radiol. 2017 Jul;27(7):2737-2743. doi: 10.1007/s00330-016-4612-z. Epub 2016 Nov 2.
2
Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.美国 2016 年癌症筛查:对当前美国癌症协会指南和癌症筛查当前问题的回顾。
CA Cancer J Clin. 2016 Mar-Apr;66(2):96-114. doi: 10.3322/caac.21336. Epub 2016 Jan 21.
3
Assessing the predictive power of newly added biomarkers.评估新添加生物标志物的预测能力。
Biom J. 2015 Sep;57(5):797-807. doi: 10.1002/bimj.201400210. Epub 2015 Jul 3.
4
Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.基于剩余终生风险的乳腺癌预防临床指南的实际问题。
J Natl Cancer Inst. 2015 May 8;107(7). doi: 10.1093/jnci/djv124. Print 2015 Jul.
5
On the use of partial area under the ROC curve for comparison of two diagnostic tests.关于使用ROC曲线下部分面积比较两种诊断试验
Biom J. 2015 Mar;57(2):304-20. doi: 10.1002/bimj.201400023. Epub 2014 Dec 23.
6
Management of women at high risk of breast cancer.乳腺癌高危女性的管理。
BMJ. 2014 Apr 28;348:g2756. doi: 10.1136/bmj.g2756.
7
On use of partial area under the ROC curve for evaluation of diagnostic performance.ROC 曲线下面积的使用评估诊断性能。
Stat Med. 2013 Sep 10;32(20):3449-58. doi: 10.1002/sim.5777. Epub 2013 Mar 18.
8
Diffusion weighted imaging (DWI) of the breast: ready for clinical practice?乳腺扩散加权成像(DWI):是否已准备好应用于临床实践?
Eur J Radiol. 2012 Sep;81 Suppl 1:S80-1. doi: 10.1016/S0720-048X(12)70032-3.
9
Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening.美国癌症筛查 2012:对当前美国癌症协会指南及癌症筛查当前问题的回顾。
CA Cancer J Clin. 2012 Mar-Apr;62(2):129-42. doi: 10.3322/caac.20143. Epub 2012 Jan 19.
10
New American Cancer Society process for creating trustworthy cancer screening guidelines.美国癌症协会创建可信癌症筛查指南的新流程。
JAMA. 2011 Dec 14;306(22):2495-9. doi: 10.1001/jama.2011.1800.